Cypress Capital’s Danimer Scientific, Inc. DNMR Stock Holding History

Cypress Capital’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8	Closed	-$181	–	388
2024 Q2	$181	Buy	+8	New	+$249	﹤0.01%	372

Other funds holding DNMR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Cypress Capital's DNMR Position: Q3 2024 in Review

Cypress Capital sold out of Danimer Scientific, Inc. (DNMR) in Q3 2024, closing a stake of 8 shares — an estimated $181 sold.

Cypress Capital first reported a position in DNMR in Q2 2024 and held it in 1 quarter. The position peaked at $181 in Q2 2024. 113 funds tracked by Wall St. Rank hold DNMR as of Q3 2024.

Cypress Capital reported no remaining Danimer Scientific, Inc. position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 8 Danimer Scientific, Inc. shares in Q3 2024, an estimated $181.
Cypress Capital first reported a position in Danimer Scientific, Inc. in Q2 2024 and held it in 1 quarter.
Cypress Capital's Danimer Scientific, Inc. position peaked at $181 in Q2 2024.
113 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.